177 related articles for article (PubMed ID: 29025083)
1. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
2. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
[TBL] [Abstract][Full Text] [Related]
5. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.
Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
Lancet Infect Dis; 2016 Feb; 16(2):219-26. PubMed ID: 26603173
[TBL] [Abstract][Full Text] [Related]
6. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
8. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of universal BCG vaccination of Japanese infants.
Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
[TBL] [Abstract][Full Text] [Related]
12. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
[TBL] [Abstract][Full Text] [Related]
13. BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England.
Rodrigues LC; Noel Gill O; Smith PG
J Epidemiol Community Health; 1991 Mar; 45(1):78-80. PubMed ID: 2045751
[TBL] [Abstract][Full Text] [Related]
14. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
[TBL] [Abstract][Full Text] [Related]
15. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
Dye C
J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
[TBL] [Abstract][Full Text] [Related]
16. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
17. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
[No Abstract] [Full Text] [Related]
18. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
[TBL] [Abstract][Full Text] [Related]
20. Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study.
Haahr S; Michelsen SW; Andersson M; Bjorn-Mortensen K; Soborg B; Wohlfahrt J; Melbye M; Koch A
Int J Epidemiol; 2016 Dec; 45(6):2122-2130. PubMed ID: 28338723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
